Boehringer Natru-Vent Comparative Claims Discontinuation Urged By NAD
This article was originally published in The Tan Sheet
Executive Summary
A Boehringer Ingelheim Consumer Healthcare print ad for Natru-Vent preservative-free nasal sprays implies preservatives found in other OTC treatments are harmful or unsafe, the Council of Better Business Bureaus' advertising division says.
You may also be interested in...
Boehringer Ingelheim Enters U.S. OTC Market With Natru-Vent Nasal Sprays
Boehringer Ingelheim Consumer Healthcare is jumping into the OTC drug market with a line of three preservative-free nasal sprays called Natru-Vent.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands